Novel method for reducing plasma cholesterol: a ligand replacement therapy.

about

A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice.

P2860

Q37228000-4180212D-3E80-4DF5-8D5E-E9EB829FA859

P2860

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

Item

http://www.wikidata.org/entity/Q35558371

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

@ast

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

@en

type

Item

label

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

@ast

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

@en

prefLabel

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

@ast

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

@en

P1476

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

@en

P2093

Dennis Goldberg

http://www.w3.org/2001/XMLSchema#string

G M Anantharamaiah

http://www.w3.org/2001/XMLSchema#string

P2860

The PCSK9 decade

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice

The discovery and development of HMG-CoA reductase inhibitors

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

The management of hyperlipidemia: whether, rather than how

Consensus conference. Lowering blood cholesterol to prevent heart disease

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

P304

83-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/CLP.14.63

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25937835

http://www.w3.org/2001/XMLSchema#string

P932

4415983

http://www.w3.org/2001/XMLSchema#string

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

about

P2860

P2860

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932